{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T07:20:58Z","timestamp":1773732058255,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.sleep.2016.04.020","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T04:01:05Z","timestamp":1470974465000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder"],"prefix":"10.1016","volume":"23","author":[{"given":"Jaime M.","family":"Monti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2016.04.020_bib0010","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.sleep.2016.04.020_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br Med Bull"},{"key":"10.1016\/j.sleep.2016.04.020_bib0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.smrv.2013.02.004","article-title":"The neurotransmitters of sleep and wake, a physiological reviews series","volume":"17","author":"Monti","year":"2013","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2016.04.020_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2013.02.006","article-title":"Paradoxical (REM) sleep genesis by the brainstem is under hypothalamic control","volume":"23","author":"Luppi","year":"2013","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.sleep.2016.04.020_bib0030","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2146\/ajhp070261","article-title":"Paliperidone for schizophrenia","volume":"65","author":"Dolder","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.sleep.2016.04.020_bib0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/oxfordjournals.bmb.a011569","article-title":"Imaging as a tool in exploring the neurodevelopmental and genetics of schizophrenia","volume":"52","author":"Frangou","year":"1996","journal-title":"Br Med Bull"},{"key":"10.1016\/j.sleep.2016.04.020_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","article-title":"Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia","volume":"20","author":"Horacek","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.sleep.2016.04.020_bib0045","series-title":"The pharmacological basis of therapeutics","first-page":"485","article-title":"Drugs and the treatment of psychiatric disorders","author":"Baldessarini","year":"2001"},{"issue":"Suppl.","key":"10.1016\/j.sleep.2016.04.020_bib0055","first-page":"13","article-title":"The pharmacokinetics of risperidone in humans: a summary","volume":"55","author":"Heykants","year":"1994","journal-title":"J Clin Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.sleep.2016.04.020_bib0060","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1046\/j.1365-2125.2000.00147.x","article-title":"Single- and multiple-dose pharmacokinetics of ziprasidone under fasting conditions in healthy male volunteers","volume":"49","author":"Miceli","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.sleep.2016.04.020_bib0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/00003088-199937030-00001","article-title":"Olanzapine: pharmacokinetic and pharmacodynamic profile","volume":"37","author":"Callaghan","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.sleep.2016.04.020_bib0070","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2165\/00003088-200140070-00003","article-title":"Clinical pharmacokinetics of quetiapine; an atypical antipsychotic","volume":"40","author":"DeVane","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.sleep.2016.04.020_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1185\/03007999709113338","article-title":"Treatment-resistant schizophrenia-the role of clozapine","volume":"14","author":"Meltzer","year":"1997","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.sleep.2016.04.020_bib0080","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcomes in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania","volume":"56","author":"Suppes","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0085","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.pnpbp.2004.05.048","article-title":"Effects of clozapine on sleep in bipolar and schizoaffective disorders","volume":"28","author":"Armitage","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-3223(96)00347-2","article-title":"Effects of clozapine on sleep. A longitudinal study","volume":"42","author":"Hinze-Selch","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0095","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.schres.2013.11.009","article-title":"Olanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literature","volume":"152","author":"Kluge","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1016\/j.sleep.2016.04.020_bib0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0165-1781(01)00284-0","article-title":"Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia","volume":"103","author":"Lee","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.sleep.2016.04.020_bib0105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-3956(96)00022-2","article-title":"The electroencephalographic sleep patterns in schizophrenic patients treated with clozapine or classical antipsychotic drugs","volume":"30","author":"Wetter","year":"1996","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.sleep.2016.04.020_bib0110","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.sleep.2016.04.020_bib0115","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4088\/JCP.v60n0410","article-title":"Risperidone augmentation of selective serotonin reuptake inhibitors in major depression","volume":"60","author":"Ostroff","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0120","first-page":"455","article-title":"Emerging treatments in the management of bipolar disorder \u2013 focus on risperidone long acting action","volume":"6","author":"El-Hage","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.sleep.2016.04.020_bib0125","doi-asserted-by":"crossref","first-page":"192","DOI":"10.4088\/JCP.v64n0212","article-title":"Risperidone augmentation decreases rapid eye movement sleep and decreases wake in treatment-resistant depressed patients","volume":"64","author":"Sharpley","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0130","series-title":"Basic and clinical science of mental and addictive disorders. Bibl. Psychiat","first-page":"219","article-title":"Effects of atypical antipsychotics on polysomnographic measures in schizophrenia","author":"Tandon","year":"1997"},{"issue":"Suppl. 3","key":"10.1016\/j.sleep.2016.04.020_bib0135","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1016\/S0924-977X(01)80310-2","article-title":"The effect of risperidone versus haloperidol on sleep patterns in schizophrenia patients \u2013 results of a double-blind, randomized pilot trial","volume":"11","author":"Haffmans","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2016.04.020_bib0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-1781(02)00009-4","article-title":"Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol","volume":"109","author":"Yamashita","year":"2002","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.sleep.2016.04.020_bib0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-244X-14-202","article-title":"Sleep architecture and cognitive changes in olanzapine-treated patients with depression: a double-blind randomized placebo controlled trial","volume":"14","author":"Lazowski","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4088\/JCP.v66n0407","article-title":"Olanzapine increases slow wave sleep and sleep continuity in SSRI-resistant depressed patients","volume":"66","author":"Sharpley","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1590\/S0100-879X2007000300011","article-title":"A double-blind comparison of the effect of the antipsychotics haloperidol and olanzapine on sleep and mania","volume":"40","author":"Moreno","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.sleep.2016.04.020_bib0160","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2004-827170","article-title":"Subchronic effect of olanzapine on sleep EEG in schizophrenic patients","volume":"37","author":"M\u00fcller","year":"2004","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-3223(98)00372-2","article-title":"Olanzapine acute administration in schizophrenia patients increases delta sleep and sleep efficiency","volume":"46","author":"Salin-Pascual","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2016.04.020_bib0170","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1345\/aph.1L320","article-title":"Effects of quetiapine on sleep in nonpsychiatric and psychiatric conditions","volume":"43","author":"Wine","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.sleep.2016.04.020_bib0175","first-page":"501","article-title":"Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression","volume":"6","author":"Gedge","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.sleep.2016.04.020_bib0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jad.2013.12.032","article-title":"Effect of quetiapine XR on depressive symptoms and sleep quality compared with lithium in patients with bipolar disorder","volume":"157","author":"Kim","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1016\/j.sleep.2016.04.020_bib0185","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.jcp.0000239798.59943.77","article-title":"Night locomotor activity and quality of sleep in quetiapine-treated patients with depression","volume":"26","author":"Todder","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.sleep.2016.04.020_bib0190","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jad.2008.06.019","article-title":"Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: improvements in quality of life and quality of sleep","volume":"111","author":"Endicott","year":"2008","journal-title":"J Affect Disord"},{"key":"10.1016\/j.sleep.2016.04.020_bib0195","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1017\/S146114571300028X","article-title":"Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies","volume":"16","author":"Trivedi","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.sleep.2016.04.020_bib0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00737-012-0314-y","article-title":"Effects of quetiapine extended release on sleep and quality of life in midlife women with major depressive disorders","volume":"16","author":"Frey","year":"2013","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.sleep.2016.04.020_bib0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jad.2013.01.021","article-title":"Effects of once-daily extended release quetiapine fumarate (quetiapine XR) on quality of life and sleep in elderly patients with major depressive disorder","volume":"149","author":"Locklear","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.sleep.2016.04.020_bib0210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/jcp.0b013e31815a884d","article-title":"Sleep quality and architecture in quetiapine, risperidone, or never-treated schizophrenia patients","volume":"27","author":"Keshavan","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.sleep.2016.04.020_bib0215","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1527-3458.2007.00008.x","article-title":"Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials","volume":"13","author":"Greenberg","year":"2007","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.sleep.2016.04.020_bib0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/2045125312467348","article-title":"Sleep architecture in ziprasidone-treated bipolar depression: a pilot study","volume":"3","author":"Baskaran","year":"2013","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1016\/j.sleep.2016.04.020_bib0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.smrv.2011.12.003","article-title":"Noradrenergic modulation of wakefulness\/arousal","volume":"16","author":"Berridge","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2016.04.020_bib0230","series-title":"REM sleep: regulation and function","first-page":"223","article-title":"The role of tuberomammillary nucleus histaminergic neurons, and of their receptors in the regulation of sleep and waking","author":"Monti","year":"2011"},{"key":"10.1016\/j.sleep.2016.04.020_bib0235","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1358\/dot.2010.46.3.1437247","article-title":"Serotonin 5-HT2A receptor antagonists in the treatment of insomnia: present status and future prospects","volume":"46","author":"Monti","year":"2011","journal-title":"Drugs Today"},{"key":"10.1016\/j.sleep.2016.04.020_bib0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/01.yco.0000218600.40593.18","article-title":"Sleep and youth suicidal behavior: a neglected field","volume":"19","author":"Liu","year":"2005","journal-title":"Curr Opin Psychiatry"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945716301009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945716301009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:11:04Z","timestamp":1761405064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945716301009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":46,"alternative-id":["S1389945716301009"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2016.04.020","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2016.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}